Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Markuszewski

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Biomarkers in Medicine|June 17, 2015
Statistical-based approach in potential diagnostic application of urinary nucleosides in urogenital tract cancerEmilia Daghir-Wojtkowiak, Wiktoria Struck-Lewicka, Malgorzata Waszczuk-Jankowska, et al.
Current Medicinal Chemistry|October 10, 2017
Metabolomic Heterogeneity of Urogenital Tract Cancers Analyzed by Complementary Chromatographic Techniques Coupled with Mass SpectrometryArlette Yumba-Mpanga, Wiktoria Struck-Lewicka, Renata Wawrzyniak, et al.
Scandinavian Journal of Urology|August 18, 2017
Overactive bladder treatment: application of methylene blue to improve the injection technique of onabotulinum toxin AMichał Szczypior, Wojciech Połom, Marcin Markuszewski, et al.
Cancers|April 30, 2021
Lipidomics as a Diagnostic Tool for Prostate CancerMagdalena Buszewska-Forajta, Paweł Pomastowski, Fernanda Monedeiro, et al.
Analytica Chimica Acta|October 8, 2018
Targeted metabolomics in bladder cancer: From analytical methods development and validation towards application to clinical samplesArlette Yumba Mpanga, Danuta Siluk, Julia Jacyna, et al.
Electrophoresis|August 21, 2007
Evaluation of different warping methods for the analysis of CE profiles of urinary nucleosidesEwa Szymańska, Michał Jan Markuszewski, Xavier Capron, et al.
Journal of Breath Research|September 24, 2020
GC-MS-based untargeted metabolomics of plasma and urine to evaluate metabolic changes in prostate cancerWiktoria Struck-Lewicka, Renata Wawrzyniak, Małgorzata Artymowicz, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 17, 2015
Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot studyWiktoria Struck-Lewicka, Marta Kordalewska, Renata Bujak, et al.
Frontiers in Molecular Biosciences|March 21, 2022
Untargeted Metabolomics Study of Three Matrices: Seminal Fluid, Urine, and Serum to Search the Potential Indicators of Prostate CancerMagdalena Buszewska-Forajta, Joanna Raczak-Gutknecht, Wiktoria Struck-Lewicka, et al.
Biochemistry and Biophysics Reports|August 15, 2022
Molecular signature of renal cell carcinoma by means of a multiplatform metabolomics analysisMarta Kordalewska, Renata Wawrzyniak, Julia Jacyna, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Biomarkers in Medicine|June 17, 2015
Statistical-based approach in potential diagnostic application of urinary nucleosides in urogenital tract cancerEmilia Daghir-Wojtkowiak, Wiktoria Struck-Lewicka, Malgorzata Waszczuk-Jankowska, et al.
Current Medicinal Chemistry|October 10, 2017
Metabolomic Heterogeneity of Urogenital Tract Cancers Analyzed by Complementary Chromatographic Techniques Coupled with Mass SpectrometryArlette Yumba-Mpanga, Wiktoria Struck-Lewicka, Renata Wawrzyniak, et al.
Scandinavian Journal of Urology|August 18, 2017
Overactive bladder treatment: application of methylene blue to improve the injection technique of onabotulinum toxin AMichał Szczypior, Wojciech Połom, Marcin Markuszewski, et al.
Cancers|April 30, 2021
Lipidomics as a Diagnostic Tool for Prostate CancerMagdalena Buszewska-Forajta, Paweł Pomastowski, Fernanda Monedeiro, et al.
Analytica Chimica Acta|October 8, 2018
Targeted metabolomics in bladder cancer: From analytical methods development and validation towards application to clinical samplesArlette Yumba Mpanga, Danuta Siluk, Julia Jacyna, et al.
Electrophoresis|August 21, 2007
Evaluation of different warping methods for the analysis of CE profiles of urinary nucleosidesEwa Szymańska, Michał Jan Markuszewski, Xavier Capron, et al.
Journal of Breath Research|September 24, 2020
GC-MS-based untargeted metabolomics of plasma and urine to evaluate metabolic changes in prostate cancerWiktoria Struck-Lewicka, Renata Wawrzyniak, Małgorzata Artymowicz, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 17, 2015
Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot studyWiktoria Struck-Lewicka, Marta Kordalewska, Renata Bujak, et al.
Frontiers in Molecular Biosciences|March 21, 2022
Untargeted Metabolomics Study of Three Matrices: Seminal Fluid, Urine, and Serum to Search the Potential Indicators of Prostate CancerMagdalena Buszewska-Forajta, Joanna Raczak-Gutknecht, Wiktoria Struck-Lewicka, et al.
Biochemistry and Biophysics Reports|August 15, 2022
Molecular signature of renal cell carcinoma by means of a multiplatform metabolomics analysisMarta Kordalewska, Renata Wawrzyniak, Julia Jacyna, et al.
Pageof 4